← FDA DRUG APPROVALS

FDA ANDA · ANDA075392

PROPOFOL

Sponsor: TEVA PARENTERAL

APPLICATION
ANDA075392
TYPE
ANDA
ORIGINAL APPROVAL
2000-09-19
LATEST ACTION
2002-10-17
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PROPOFOLDiscontinued
PROPOFOL 10MG/ML · INJECTABLE · INJECTION

Approval history

2002-10-17Labeling · Supplement 4AP
2002-03-06Manufacturing (CMC) · Supplement 3AP
2001-03-20Manufacturing (CMC) · Supplement 1AP
2000-11-16Labeling · Supplement 2AP
2000-09-19OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →